OAR 847-065-0045: Approval of Independent Clinical Evaluators
Edition: Current OARD snapshotEffective: 2026-01-12Last verified: 2026-09-07
(1) To be approved by the Board as an independent clinical evaluator, an evaluator must be: (a) Licensed as required by the jurisdiction in which the evaluator works; (b) Able to provide a comprehensive assessment of and written report describing a licensee’s diagnosis, degree of impairment, and treatment recommendations; and (c) Able to facilitate toxicology testing of the licensee at intake. (2) The Board reserves the right to not approve an independent clinical evaluator for any reason. (3) The Board or contractor will not accept an evaluator as independent in a particular case if, in the Board’s or contractor’s judgment, the evaluator’s judgment is likely to be influenced by a personal or professional relationship with a licensee.
Official history and status
Statutory/Other Authority: ORS 676.190, 677.265 & 676.200
Statutes/Other Implemented: ORS 676.190, 676.185, 676.200, 676.194 & OL 2025, chapter 499, sections 2-3
History: OMB 4-2026, amend filed 01/12/2026, effective 01/12/2026 OMB 19-2022, amend filed 10/12/2022, effective 10/12/2022 OMB 33-2012, f. & cert. ef. 10-22-12 OMB 17-2012(Temp), f. & cert. ef. 7-31-12 thru 1-15-13 OMB 9-2011, f. & cert. ef. 4-25-11 BME 20-2010, f. & cert. ef. 10-25-10 BME 15-2010(Temp), f. & cert. ef. 8-3-10 thru 1-18-11
This rule cites
No citations extracted.
Cited by
No inbound citations found.
Official source: https://secure.sos.state.or.us/oard/